Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Psychedelic/Assisted Therapies

Recent news which mentions Psychedelic/Assisted Therapies

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Orange Photonics: New High-Tech Testing For Psychedelic Products
Tags Markets News psilocybin mushrooms
From Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
Tickers CYBN DMT DMTTF
Tags DMTTF DMT Markets
From Benzinga
Congress Halts Hearing On Psychedelics & Veterans As House Speaker Drama Continues
Tags FDA Benzinga Psychedelic/Assisted Therapies
From Benzinga
New Survey Suggests Psilocybin Eases Psychological Distress From Childhood Trauma
Tags Markets Cannabis Market News
From Benzinga
EXCLUSIVE: Reason For Hope On Veteran Group Efforts, Comments To FDA & 2023 Expectations
Tags Management Government News
From Benzinga
Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M
Tickers LSDI
Tags Markets Cannabis Market News
From Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
Tickers ATAI CMPS CYBN DMTTF
Tags Penny Stocks Psychedelic/Assisted Therapies Benzinga
From Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
Tickers AWKNF
Tags ScholarGPS Drug Science News
From Benzinga
Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy
Tags Benzinga Psychedelic/Assisted Therapies Cannabis
From Benzinga
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
Tickers CYBN DMTTF
Tags Markets DMTTF Short/Acting Psychedelics
From Benzinga
Pioneering Hope: Inside The Veteran's Organization Advancing Psychedelics Reform Policy
Tags Management Legal Interview
From Benzinga
EXCLUSIVE: Understanding Real Estate For Psychedelic Treatments Boosted By Geospatial Mapping
Tickers AAPL IBM
Tags Psychedelic/Assisted Therapies AAPL HealingMaps
From Benzinga
EXCLUSIVE: The Need To Enhance Psychedelic Therapy Infrastructure, Data-Driven Solutions
Tags Cannabis Real Estate Market News
From Benzinga
Maine's Portland Leads Drug Policy Reform, Decriminalizing Psychedelic Plants And Fungi
Tags Management Psychedelics Legal
From Benzinga
Decoding Insurance Reimbursement For Psychedelic-Assisted Therapy With BrainFutures Guide
Tags Market News BrainFutures Psychedelic Therapy Reimbursement
From Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
Tickers ATAI
Tags Markets Management ATAI
From Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
Tickers CYBN
Tags Psychedelic/Assisted Therapies Penny Stocks Benzinga
From Benzinga
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
Tickers BNOX CYBN MRK
Tags Benzinga Point72 Asset Management Psychedelic/Assisted Therapies
From Benzinga
Insider's Look At Psychedelics Industry On Risk Management, Gray Market & Cannabis Industry
Tags Exclusives Markets AlphaRoot
From Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
Tickers GHRS
Tags Cannabis Markets Market News
From Benzinga
Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules
Tags Market News Gov/ Gavin Newsom Cannabis
From Benzinga
Psychedelic Therapy Providers: Risk Management Perspective From A Cannabis Insurance Specialist
Tags Psychedelics Market News Cannabis
From Benzinga
Argentina's Nacho Bottinelli On Psychedelics In Latin America: 'Brazil Opened A Giant Portal To Me'
Tags News Markets Exclusives
From Benzinga
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Tickers ATAI CMPS CYBN DMTTF
Tags SILO PSIL Market News
From Benzinga
Psychedelics Reform Update: Massachusetts, Pennsylvania, Maine, California, Michigan, Minnesota, Indiana
Tags Rumors Psychedelics Market News
From Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
Tickers PHRRF
Tags Abbreviated New Drug Application Markets Top Stories
From Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
Tickers CYBN
Tags Markets Guidance Fluence
From Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
Tickers CYBN DMTTF
Tags News CYBN Management
From Benzinga
Defense Dept. Grants $1M To Yale & Transcend Therapeutics To Study PTSD Therapy
Tags Psychedelics Department of Defense News
From Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
Tickers ATAI CMPS CYBN DMTTF
Tags Market News PSIL SILO
From Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.